<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7267113\results\search\disease\results.xml">
  <result pre="&amp;amp; Dir2RangarajanJayanthiMD, FRCP(Glasgow)Prof of Medicine, Dean3RathinamJeyalalithaMDProf of Pharmacology3NatarajanMuruganMDAssociate Prof of" exact="Pulmonary" post="Medicine3RamachandranArunkumarPhDResearch Scientist I1[1], Multidisciplinary Research Unit (MRU)Madras Medical CollegeChennaiTamil"/>
  <result pre=", This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
  <result pre="public health emergency.file:JMV-9999-na.pdf Abstract Abstract The recent emergence of coronavirus" exact="disease" post="2019 (COVIDâ€�19) pandemic has reassessed the usefulness of historic"/>
  <result pre="clinical symptoms after administration of convalescent plasma. Based on the" exact="limited" post="scientific data, CPT therapy in COVIDâ€�19 patients appears safe,"/>
  <result pre="J Med Virol. 2020;1â€&quot;9. 10.1002/jmv.2596131502247 1 INTRODUCTION The recent coronavirus" exact="disease" post="2019 (COVIDâ€�19) epidemic developed into an unprecedented global public"/>
  <result pre="treatment of COVIDâ€�19 caused by novel coronavirus SARSâ€�CoVâ€�2 has been" exact="limited" post="to general supportive care, with provision of critical care"/>
  <result pre="data for the studies involving COVIDâ€�19 are still scarce and" exact="limited" post="to data from China, Spain, Italy, United States of"/>
  <result pre="outcomes. Passive immunization therapy has been successfully used to treat" exact="infectious diseases" post="back to the 1890s. An individual who is sick"/>
  <result pre="back to the 1890s. An individual who is sick with" exact="infectious diseases" post="and recovers has blood drawn and screened for particular"/>
  <result pre="neutralizing antibodies can be administered in individuals with specified clinical" exact="disease" post="to reduce symptoms and mortality. Hence, convalescent plasma transfusion"/>
  <result pre="Outcomes The outcome of interest was clinical effects, survival benefits," exact="viral" post="load &amp;amp; antibody titer status and adverse events. 2.6"/>
  <result pre="opinion of a third reviewer. The extracted information included mortality," exact="viral" post="load, viral antibody titers, clinical benefits, and adverse events."/>
  <result pre="a third reviewer. The extracted information included mortality, viral load," exact="viral" post="antibody titers, clinical benefits, and adverse events. Outcomes were"/>
  <result pre="of hospital stay during transfusion, critical care interventions, clinical outcome," exact="viral" post="load, and adverse events. The five studies include a"/>
  <result pre="viral load, and adverse events. The five studies include a" exact="total" post="of 27 patients who received CPT therapies for COVIDâ€�19."/>
  <result pre="dosage Antiviral (antimicrobial drugs) Administrated day Status during CPT Outcome" exact="Viral" post="load Severe adverse events &amp;amp; treatment complications Duan et"/>
  <result pre="(antimicrobial drugs) Administrated day Status during CPT Outcome Viral load" exact="Severe" post="adverse events &amp;amp; treatment complications Duan et al6 China"/>
  <result pre="Varying degrees of absorption of lung lesions within 7 d" exact="Viral" post="load undetectable (nâ€‰=â€‰7), Neutralizing antibody increased rapidly up to"/>
  <result pre="All drugs discontinued except methylprednisolone, Chest images absorption of interstitial" exact="pneumonia" post="(13th dâ€�17th d), Discharged on (19th d) Negative (18th"/>
  <result pre="d) Negative (18th d) No adverse reactions 73â€‰y/M, HTN &amp;amp;" exact="chronic" post="renal fâ€�ure 2400â€‰mL in 8 doses arbidol, lopinavirâ€�ritonavir, oseltamivir,"/>
  <result pre="oseltamivir, ribavirin, interferon alphaâ€�2b After admission 15th d Critically ill" exact="Acute" post="respiratory failure invasive mechanical ventilation in Vâ€�V ECMO Positive"/>
  <result pre="ribavirin, interferon alphaâ€�2b After admission 15th d Critically ill Acute" exact="respiratory" post="failure invasive mechanical ventilation in Vâ€�V ECMO Positive antiâ€�SARSâ€�CoVâ€�2"/>
  <result pre="at 12 h interval hydroxychloroquine, lopinavir/ritonavir After admission 10th d" exact="Severe" post="ARDS, mechanical ventilation Weaned from the mechanical ventilator, underwent"/>
  <result pre="arbidol Fatigue, shortness of breath, oxygen therapy through nasal catheter," exact="respiratory" post="distress, Multiple consolidation Symptoms improved, alleviation of respiratory distress,"/>
  <result pre="shortness of breath, oxygen therapy through nasal catheter, respiratory distress," exact="Multiple" post="consolidation Symptoms improved, alleviation of respiratory distress, twoâ€�fold increase"/>
  <result pre="nasal catheter, respiratory distress, Multiple consolidation Symptoms improved, alleviation of" exact="respiratory" post="distress, twoâ€�fold increase in IgM and IgG titers, consolidation"/>
  <result pre="Chest CTâ€�Multiple GGOs, reticular opacities, and fibrosis streak, Symptoms improved," exact="complete" post="resolution consolidation,gradually resolution of GGOs, IgM and IgG titers"/>
  <result pre="GGOs, IgM and IgG titers increased Discharged Not mentioned 63/F" exact="Sjogren syndrome" post="200â€‰mL After symptom 40th d Fever, cough, shortness of"/>
  <result pre="IgM and IgG titers increased Discharged Not mentioned 63/F Sjogren" exact="syndrome" post="200â€‰mL After symptom 40th d Fever, cough, shortness of"/>
  <result pre="Fever, cough, shortness of breath and myalgia, Chest CTâ€� Extensive" exact="bilateral" post="GGOs, respiratory distress Symptoms improved, GGOs resolved, discharged 54th"/>
  <result pre="shortness of breath and myalgia, Chest CTâ€� Extensive bilateral GGOs," exact="respiratory" post="distress Symptoms improved, GGOs resolved, discharged 54th d Abbreviations:"/>
  <result pre="distress Symptoms improved, GGOs resolved, discharged 54th d Abbreviations: ARDS," exact="acute" post="respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; COVIDâ€�19,"/>
  <result pre="Symptoms improved, GGOs resolved, discharged 54th d Abbreviations: ARDS, acute" exact="respiratory" post="distress syndrome; COPD, chronic obstructive pulmonary disease; COVIDâ€�19, coronavirus"/>
  <result pre="discharged 54th d Abbreviations: ARDS, acute respiratory distress syndrome; COPD," exact="chronic" post="obstructive pulmonary disease; COVIDâ€�19, coronavirus disease 2019; CP, convalescent"/>
  <result pre="d Abbreviations: ARDS, acute respiratory distress syndrome; COPD, chronic obstructive" exact="pulmonary" post="disease; COVIDâ€�19, coronavirus disease 2019; CP, convalescent plasma; CT,"/>
  <result pre="respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; COVIDâ€�19, coronavirus" exact="disease" post="2019; CP, convalescent plasma; CT, computed tomography; Ct, computed"/>
  <result pre="IgM, immunoglobulin M; LFNO, lowâ€�flow nasal cannula oxygenation; SARSâ€�CoVâ€�2, severe" exact="acute" post="respiratory syndrome coronavirus 2; SOFA, sequential organ failure assessment."/>
  <result pre="immunoglobulin M; LFNO, lowâ€�flow nasal cannula oxygenation; SARSâ€�CoVâ€�2, severe acute" exact="respiratory" post="syndrome coronavirus 2; SOFA, sequential organ failure assessment. (C)"/>
  <result pre="M; LFNO, lowâ€�flow nasal cannula oxygenation; SARSâ€�CoVâ€�2, severe acute respiratory" exact="syndrome" post="coronavirus 2; SOFA, sequential organ failure assessment. (C) John"/>
  <result pre="Ltd., This article is being made freely available through PubMed" exact="Central" post="as part of the COVID-19 public health emergency response."/>
  <result pre="the male patients (nâ€‰=â€‰15) were larger in number than the" exact="female" post="patients (nâ€‰=â€‰12). The age of the patients across the"/>
  <result pre="given CPT including COPD/Bronchitis (nâ€‰=â€‰2), Cardiovascular and cerebrovascular diseases (nâ€‰=â€‰1)," exact="hypertension" post="(nâ€‰=â€‰7). Among hypertensive patients, one had mitral insufficiency, another"/>
  <result pre="Among hypertensive patients, one had mitral insufficiency, another one had" exact="chronic" post="renal failure. In addition, one 63â€�yearâ€�old female patient presented"/>
  <result pre="hypertensive patients, one had mitral insufficiency, another one had chronic" exact="renal failure." post="In addition, one 63â€�yearâ€�old female patient presented with Sjogren"/>
  <result pre="another one had chronic renal failure. In addition, one 63â€�yearâ€�old" exact="female" post="patient presented with Sjogren syndrome. Another 31 years aged"/>
  <result pre="renal failure. In addition, one 63â€�yearâ€�old female patient presented with" exact="Sjogren syndrome." post="Another 31 years aged female COVIDâ€�19 patient was pregnant"/>
  <result pre="female patient presented with Sjogren syndrome. Another 31 years aged" exact="female" post="COVIDâ€�19 patient was pregnant with a gestation period of"/>
  <result pre="a very long history of use in the treatment of" exact="infectious disease." post="Its use has been well documented during the outbreak"/>
  <result pre="the outbreak of many diseases at various periods, including spanish" exact="Influenza A (H1N1)" post="infections in 1915 to 1917,11 severe acute respiratory syndrome"/>
  <result pre="many diseases at various periods, including spanish Influenza A (H1N1)" exact="infections" post="in 1915 to 1917,11 severe acute respiratory syndrome (SARS)"/>
  <result pre="spanish Influenza A (H1N1) infections in 1915 to 1917,11 severe" exact="acute" post="respiratory syndrome (SARS) in 2003,12 pandemic 2009 influenza A"/>
  <result pre="Influenza A (H1N1) infections in 1915 to 1917,11 severe acute" exact="respiratory" post="syndrome (SARS) in 2003,12 pandemic 2009 influenza A (H1N1),13"/>
  <result pre="A (H1N1) infections in 1915 to 1917,11 severe acute respiratory" exact="syndrome" post="(SARS) in 2003,12 pandemic 2009 influenza A (H1N1),13 avian"/>
  <result pre="respiratory syndrome (SARS) in 2003,12 pandemic 2009 influenza A (H1N1),13" exact="avian influenza" post="A (H5N1),14 several hemorrhagic fevers such as Ebola,15 and"/>
  <result pre="A (H5N1),14 several hemorrhagic fevers such as Ebola,15 and other" exact="viral" post="infections. In addition, studies show convalescent plasma antibodies that"/>
  <result pre="plasma antibodies that can limit the virus reproduction in the" exact="acute" post="phase of infection and help clear the virus, which"/>
  <result pre="can limit the virus reproduction in the acute phase of" exact="infection" post="and help clear the virus, which is beneficial to"/>
  <result pre="in which three received HFNO and two received conventional LFNO." exact="Acute respiratory distress syndrome" post="(ARDS) were reported in 17 patients in which 7"/>
  <result pre="which three received HFNO and two received conventional LFNO. Acute" exact="respiratory" post="distress syndrome (ARDS) were reported in 17 patients in"/>
  <result pre="received HFNO and two received conventional LFNO. Acute respiratory distress" exact="syndrome" post="(ARDS) were reported in 17 patients in which 7"/>
  <result pre="most studies revealed data of discharge from hospital (nâ€‰=â€‰15). 4.4" exact="Viral" post="load and antibody titer levels after CPT All five"/>
  <result pre="CPT All five studies found that CPT significantly reduces the" exact="viral" post="load and increase the level of neutralizing antibody over"/>
  <result pre="load and increase the level of neutralizing antibody over time." exact="Viral" post="loads also decreased and became negative between day 1"/>
  <result pre="treatment due to underlying diseases and multiple organ failure. 4.7" exact="Severe" post="adverse events and treatment complications CPT was well tolerated"/>
  <result pre="A lack of highâ€�quality RCT studies and relevant literature paucity" exact="limited" post="our analyses. All the reported studies were predominately case"/>
  <result pre="of India. References REFERENCES 1collab: World Health Organization . Coronavirus" exact="disease" post="2019 (COVIDâ€�19) â€� Situation Repor â€� 90 (April 19,"/>
  <result pre="2020. 2collab: World Health Organization . Clinical management of severe" exact="acute" post="respiratory infection (SARI) when COVIDâ€�19 disease is suspected. Interim"/>
  <result pre="2collab: World Health Organization . Clinical management of severe acute" exact="respiratory" post="infection (SARI) when COVIDâ€�19 disease is suspected. Interim guidance"/>
  <result pre="World Health Organization . Clinical management of severe acute respiratory" exact="infection" post="(SARI) when COVIDâ€�19 disease is suspected. Interim guidance 13"/>
  <result pre="Clinical management of severe acute respiratory infection (SARI) when COVIDâ€�19" exact="disease" post="is suspected. Interim guidance 13 March 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed"/>
  <result pre="Use of convalescent plasma therapy in two covidâ€�19 patients with" exact="acute" post="respiratory distress syndrome in Korea. J Korean Med Sci."/>
  <result pre="of convalescent plasma therapy in two covidâ€�19 patients with acute" exact="respiratory" post="distress syndrome in Korea. J Korean Med Sci. 2020;35(14):e149.32281317"/>
  <result pre="plasma therapy in two covidâ€�19 patients with acute respiratory distress" exact="syndrome" post="in Korea. J Korean Med Sci. 2020;35(14):e149.32281317 10YeMingxiang, FuDian,"/>
  <result pre="mortality in patients with severe pandemic influenza A (H1N1) 2009" exact="virus infection." post="Clin Infect Dis. 2011;52(4):447â€�456.21248066 14ZhouB, ZhongN, GuanY. Treatment with"/>
  <result pre="blood or plasma collected from patients recovered from Ebola virus" exact="disease" post="for transfusion, as an empirical treatment during outbreaks. https://www.who.int/csr/resources/publications/ebola/convalescent-treatment/en/"/>
 </snippets>
</snippetsTree>
